HPLC assets acquired

Dionex has entered into an asset purchase agreement with ESA Biosciences that will see the company purchase its HPLC related products, HPLC clinical assays, laboratory services and assets. This will include three HPLC detector families, including a universal charged aerosol detector for targeting pharmaceutical and biopharmaceutical development, manufacturing and QA/QC processes, which will be sold in conjunction with Dionex’s HPLC equipment, or directly on third party HPLC systems.

"ESA’s electrochemical detector family, the CoulArray multi-electrode array and the Coulochem detectors will expand our HPLC offering and help us serve our customer demands by providing a broader and stronger spectrum of sensitive and robust HPLC and UHPLC application solutions" said Dr Frank Witney, president and CEO of Dionex.

"We see excellent synergy with Dionex from a technology perspective," said Dr Jasmine Gruia-Gray, president of ESA Biosciences, Life Sciences Tools Business Unit. "Our combined strength in separation sciences and universal and UHPLC/HPLC detector innovation will provide our customers an industry standard comprehensive set of analytical solutions across a wide range of applications industries."

For more on Dionex visit www.dionex.com and for more on ESA Biosciences visit www.esainc.com